Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system

Juline Poirson1, Elise Biquand2, Marie-Laure Straub1

  • 1Ecole Supérieure de Biotechnologie Strasbourg, UMR-7242, CNRS, Université de Strasbourg, Illkirch, France.

The FEBS Journal
|August 9, 2017
PubMed

Insights

Researchers identified novel interactions between human papillomavirus (HPV) oncoproteins E6 and E7 and the ubiquitination system. This study reveals new viral strategies targeting host protein regulation for replication and immune evasion.

Area of Science:

  • Biochemistry and Molecular Biology
  • Virology
  • Cellular Biology

Background:

  • Protein ubiquitination and deubiquitination are crucial cellular processes regulating protein fate, catalyzed by ubiquitin ligases and deubiquitinases (DUBs).
  • The Ub-proteasome system (UPS) is frequently exploited by viruses, including human papillomavirus (HPV), to facilitate viral replication and evade host immune responses.
  • Understanding viral interactions with the UPS is key to deciphering viral pathogenesis and developing antiviral strategies.

Discussion:

  • This study screened a library of UPS-related cDNAs to identify novel partners of HPV16 E6 and E7 oncoproteins using a protein complementation assay.
  • HPV16 E6 was found to interact with E3 ubiquitin ligases (E6AP, MGRN1, LNX3, LNX4) and the DUB USP15, with specific binding preferences observed for LNX3 and LNX4 across different HPV types.
  • HPV16 E7 interacted with various UPS components, including Cullin 3-RING and Cullin 4-RING E3 ligase adaptors, RING-type E3 ligases involved in innate immunity, and DUBs (USP29, USP33), with binding mediated by its C-terminal region.

Key Insights:

  • HPV16 E6 interacts with multiple E3 ubiquitin ligases and a DUB, suggesting multifaceted regulation of host protein turnover.
  • HPV16 E7 engages with diverse UPS factors, including those critical for innate immunity, highlighting viral subversion of host defense mechanisms.
  • Specific interactions, like LNX3 with high-risk HPV E6 and LNX4 with HPV16 E6, offer insights into HPV type-specific viral strategies.
  • The C-terminal region of HPV16 E7 is critical for its interactions with UPS components, distinct from the LxCxE motif.

Outlook:

  • The identified interactions provide a foundation for further investigation into the functional consequences of HPV oncoprotein engagement with the UPS.
  • This work establishes a robust screening strategy for discovering host-pathogen interactions within the ubiquitination system.
  • Further research could explore therapeutic interventions targeting these newly identified viral-host protein interactions to combat HPV infections.

Related Concept Videos

Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.3K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.8K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.4K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.0K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.8K
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
1.9K